BioCentury
ARTICLE | Clinical News

Dulera mometasone/formoterol regulatory update

August 1, 2011 7:00 AM UTC

FDA accepted for review an sNDA for Dulera mometasone/formoterol to treat chronic obstructive pulmonary disease (COPD). The PDUFA date is not disclosed. The fixed-dose combination of mometasone, an in...